Health - Resources and discussion for everything health-related

2400 readers

558 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 2 years ago

MODERATORS

WhoRoger@lemmy.world

RoyalEngineering@lemmy.world

Awa@lemmy.world

166

FDA says decongestant in many cold medicines doesn't work. So what does? (apnews.com)

submitted 3 days ago* (last edited 2 days ago) by MicroWave@lemmy.world to c/health@lemmy.world

57 comments fedilink hide all child comments

Summary

The FDA has proposed phasing out oral phenylephrine, a common decongestant in cold medicines like Sudafed PE and DayQuil, after studies showed it is no more effective than a placebo.

The drug, ineffective when swallowed due to breakdown in the stomach, remains usable in nasal sprays.

Alternatives include pseudoephedrine, nasal sprays, and steroid treatments like Flonase.

The regulatory process to remove phenylephrine could take over a year, but experts argue removing ineffective options will help consumers choose better remedies for congestion. Drugmakers are expected to challenge the proposal.

you are viewing a single comment's thread
view the rest of the comments

[–] crozilla@lemmy.world 10 points 2 days ago

F these soulless business associations:

For now, the Consumer Healthcare Products Association — which represents medicine makers — wants the products to stay available, saying Americans deserve “the option to choose the products they prefer for self-care.”

Hatton says he and his colleagues disagree: “Our position is that choosing from something that doesn’t work isn’t really a choice.”